Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antivirogram or phenosense: a comparison of their reproducibility and an analysis of their correlation.

Antiviral therapy - 1 Oct 2004

Wang Kai, Samudrala Ram, Mittler John E

Abstract excerpt

The Antivirogram and PhenoSense assays are widely used phenotypic tests for HIV drug resistance. There are limited data on the reproducibility of each assay, and little is known about the correlation between the two. Using data from the Stanford HIV drug resistance database, we performed a compre...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Reagent Kits, Diagnostic

Share to Reproducibility of Results

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 15535407

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15535407-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antivirogram or phenosense: a comparison of their reproducibility and an analysis of their correlation.PMID 15535407Read ↗

Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assays.Semantic proximity Read ↗

A direct comparison of drug susceptibility to HIV type 1 from antiretroviral experienced subjects as assessed by the antivirogram and PhenoSense assays and by seven resistance algorithms.Semantic proximity Read ↗

A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.Semantic proximity Read ↗

Resistance assay update.Semantic proximity Read ↗

Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.Semantic proximity Read ↗

Phenotypic assays become widely available.Semantic proximity Read ↗

A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.Semantic proximity Read ↗

Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1.Semantic proximity Read ↗

Short communication prevalence of susceptibility to etravirine by genotype and phenotype in samples received for routine HIV type 1 resistance testing in the United States.Semantic proximity Read ↗

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1.Semantic proximity Read ↗

Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis.Semantic proximity Read ↗

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.